Lirilumab and Nivolumab With 5-Azacitidine in Patients With Myelodysplastic Syndromes (MDS)
Clinical trial NCT02599649 · TERMINATED
Trial details
- NCT number
- NCT02599649
- Sponsor
- M.D. Anderson Cancer Center
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-03-21
- Primary completion
- 2019-01-30
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.